Request for Covid-19 Impact Assessment of this Report

Healthcare

Middle East and Africa Drug Safety Solutions and Pharmacovigilance Market – Industry Trends and Forecast to 2026

  • DAT3308066
  • 90 Pages
  • October 2019
  • Healthcare
Download Sample    Get Discount   
 
Middle East and Africa drug safety solutions and pharmacovigilance market is projected to register a substantial CAGR in the forecast period of 2019 to 2026. The new market report contains data for the historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation:

By Type (Software, Services), End Users (Biotechnology & Pharmaceuticals, Contract Research Organizations (CROS), Hospitals, KPOs/BPOs, Healthcare Providers), Distribution Channel (Direct Sales, Retail Sales), Country (South Africa, South Arabia, UAE, Kuwait, Rest of Middle East & Africa)

Some of the major factor contributing to the growth of the market is:

• Growth opportunities in developing countries

Market Players:

The key market players for Middle East and Africa drug safety solutions and pharmacovigilance market are listed below:

• Pharmaceutical Product Development, LLC

• Drug Safety Solutions Limited

• C3i

• Worldwide Clinical Trials

• Bioclinica

• United Biosource LLC

• Ennov

• AB Cube

• Covance Inc.

• Accenture

• PRA Health Sciences, Inc.

• Ergomed

• IQVIA

• Genpact

• Cognizant

• Parexel International Corporation

• ArisGlobal

• ICON plc

• Oracle

• Syneos Health

TABLE OF CONTENTS

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.10 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 INCREASING NUMBER OF CLINICAL TRIALS

3.1.2 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATIONS

3.1.3 INCREASE IN R & D EXPENDITURE BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES

3.1.4 INCREASE IN THE NUMBER OF ADVERSE DRUG REACTIONS (ADRS)

3.2 RESTRAINT

3.2.1 HIGH COST OF DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE

3.3 OPPORTUNITIES

3.3.1 AUTOMATION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE

3.3.2 RESEARCH COLLABORATIONS AND PARTNERSHIPS

3.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS

3.4 CHALLENGE

3.4.1 THE MISREPORTING AND MISCODING OF ADVERSE EVENTS

4 EXECUTIVE SUMMARY

5 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE

5.1 OVERVIEW

5.2 SOFTWARE

5.2.1 ADVERSE EVENT REPORTING SOFTWARE

5.2.1.1 ON-PREMISE

5.2.1.2 CLOUD BASED

5.2.2 DRUG SAFETY AUDITS SOFTWARE

5.2.2.1 ON-PREMISE

5.2.2.2 CLOUD BASED

5.2.3 DATA MANAGEMENT SOFTWARE

5.2.3.1 ON-PREMISE

5.2.3.2 CLOUD BASED

5.2.4 FULLY INTEGRATED SOFTWARE

5.2.4.1 ON-PREMISE

5.2.4.2 CLOUD BASED

5.2.5 ISSUE TRACKING SOFTWARE

5.2.5.1 ON-PREMISE

5.2.5.2 CLOUD BASED

5.2.6 CLINICAL TRIAL MANAGEMENT SOLUTION

5.2.6.1 ON-PREMISE

5.2.6.2 CLOUD BASED

5.2.7 REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE

5.2.7.1 ON-PREMISE

5.2.7.2 CLOUD BASED

5.2.8 MEDICAL AFFAIRS SOFTWARE

5.2.8.1 ON-PREMISE

5.2.8.2 CLOUD BASED

5.2.9 OTHERS

5.2.9.1 ON-PREMISE

5.2.9.2 CLOUD BASED

5.3 SERVICES

5.3.1 CLINICAL DATA MANAGEMENT

5.3.1.1 DATA ENTRY AND CASE PROCESSING

5.3.1.2 CLINICAL TRIAL MONITORING

5.3.1.3 CLINICAL TRIAL SAFETY SUBMISSIONS

5.3.1.4 CASE PROCESSING (SAES)

5.3.1.5 OTHERS

5.3.2 DRUG SAFETY SOLUTIONS

5.3.2.1 QUALITY AND MEDICAL REVIEW

5.3.2.2 LITERATURE AND SOCIAL MEDIA MONITORING

5.3.2.3 SAFETY DATABASE

5.3.2.4 INDIVIDUAL CASE STUDY REPORT

5.3.2.5 PERIODIC REPORTS

5.3.2.6 MEDICAL LITERATURE SEARCH

5.3.2.7 SIGNAL DETECTION

5.3.2.8 EXPEDITED REPORTS

5.3.2.9 OTHERS

5.3.3 AGGREGATE SAFETY REPORTING

5.3.4 REGULATORY SERVICES

5.3.4.1 SAFETY REGULATORY SUBMISSIONS

5.3.4.2 POST-MARKETING SURVEILLANCE

5.3.4.3 MEDICAL DEVICE VIGILANCE

5.3.4.4 REGULATORY CONSULTING

5.3.4.5 OTHERS

5.3.5 RISK MANAGEMENT SERVICES

5.3.6 MEDICAL INFORMATION CALL CENTER SERVICES

5.3.7 AUDIT SERVICES

5.3.8 TRAINING SUPPORT SERVICES

5.3.9 OTHERS

6 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USERS

6.1 OVERVIEW

6.2 PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRIES

6.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)

6.4 HOSPITALS

6.5 KPOS/BPOS

6.6 HEALTHCARE PROVIDERS

6.7 OTHERS

7 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL

7.1 OVERVIEW

7.2 DIRECT SALES

7.3 RETAIL SALES

8 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY GEOGRAPHY

8.1 MIDDLE EAST AND AFRICA

8.1.1 UAE

8.1.2 SAUDI ARABIA

8.1.3 KUWAIT

8.1.4 SOUTH AFRICA

8.1.5 REST OF MIDDLE EAST AND AFRICA

9 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, COMPANY LANDSCAPE

9.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

10 COMPANY PROFILE

10.1 SYNEOS HEALTH

10.1.1 COMPANY SNAPSHOT

10.1.2 REVENUE ANALYSIS

10.1.3 COMPANY SHARE ANALYSIS

10.1.4 SOLUTION PORTFOLIO

10.1.5 RECENT DEVELOPMENT

10.2 COVANCE INC. (A SUBSIDIARY OF LABCORP)

10.2.1 COMPANY SNAPSHOT

10.2.2 REVENUE ANALYSIS

10.2.3 COMPANY SHARE ANALYSIS

10.2.4 SERVICE PORTFOLIO

10.2.5 RECENT DEVELOPMENTS

10.3 COGNIZANT

10.3.1 COMPANY SNAPSHOT

10.3.2 REVENUE ANALYSIS

10.3.3 COMPANY SHARE ANALYSIS

10.3.4 SOLUTION PORTFOLIO

10.3.5 RECENT DEVELOPMENT

10.4 ACCENTURE

10.4.1 COMPANY SNAPSHOT

10.4.2 REVENUE ANALYSIS

10.4.3 COMPANY SHARE ANALYSIS

10.4.4 SERVICE PORTFOLIO

10.4.5 RECENT DEVELOPMENTS

10.5 PAREXEL INTERNATIONAL CORPORATION

10.5.1 COMPANY SNAPSHOT

10.5.2 PRODUCT PORTFOLIO

10.5.3 RECENT DEVELOPMENTS

10.6 ORACLE

10.6.1 COMPANY SNAPSHOT

10.6.2 REVENUE ANALYSIS

10.6.3 SOLUTION PORTFOLIO

10.6.4 RECENT DEVELOPMENT

10.7 AB CUBE

10.7.1 COMPANY SNAPSHOT

10.7.2 SOLUTION PORTFOLIO

10.7.3 RECENT DEVELOPMENT

10.8 ARISMIDDLE EAST AND AFRICA

10.8.1 COMPANY SNAPSHOT

10.8.2 PRODUCT PORTFOLIO

10.8.3 RECENT DEVELOPMENTS

10.9 BIOCLINICA

10.9.1 COMPANY SNAPSHOT

10.9.2 SERVICE PORTFOLIO

10.9.3 RECENT DEVELOPMENTS

10.10 C3I

10.10.1 COMPANY SNAPSHOT

10.10.2 REVENUE ANALYSIS

10.10.3 SERVICE PORTFOLIO

10.10.4 RECENT DEVELOPMENTS

10.11 DRUG SAFETY SOLUTIONS LIMITED

10.11.1 COMPANY SNAPSHOT

10.11.2 SERVICE PORTFOLIO

10.11.3 RECENT DEVELOPMENT

10.12 ENNOV

10.12.1 COMPANY SNAPSHOT

10.12.2 PRODUCT PORTFOLIO

10.12.3 RECENT DEVELOPMENTS

10.13 ERGOMED PLC

10.13.1 COMPANY SNAPSHOT

10.13.2 REVENUE ANALYSIS

10.13.3 SERVICE PORTFOLIO

10.13.4 RECENT DEVELOPMENTS

10.14 GENPACT

10.14.1 COMPANY SNAPSHOT

10.14.2 REVENUE ANALYSIS

10.14.3 PRODUCT PORTFOLIO

10.14.4 RECENT DEVELOPMENTS

10.15 ICON PLC

10.15.1 COMPANY SNAPSHOT

10.15.2 REVENUE ANALYSIS

10.15.3 SERVICE PORTFOLIO

10.15.4 RECENT DEVELOPMENTS

10.16 IQVIA

10.16.1 COMPANY SNAPSHOT

10.16.2 REVENUE ANALYSIS

10.16.3 SOLUTION PORTFOLIO

10.16.4 RECENT DEVELOPMENTS

10.17 PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC.

10.17.1 COMPANY SNAPSHOT

10.17.2 SERVICE PORTFOLIO

10.17.3 RECENT DEVELOPMENTS

10.18 PHARMACEUTICAL RESEARCH ASSOCIATES INC.

10.18.1 COMPANY SNAPSHOT

10.18.2 REVENUE ANALYSIS

10.18.3 SOLUTION PORTFOLIO

10.18.4 RECENT DEVELOPMENTS

10.19 UNITED BIOSOURCE LLC

10.19.1 COMPANY SNAPSHOT

10.19.2 SERVICE PORTFOLIO

10.19.3 RECENT DEVELOPMENT

10.20 WORLDWIDE CLINICAL TRIALS

10.20.1 COMPANY SNAPSHOT

10.20.2 SERVICE PORTFOLIO

10.20.3 RECENT DEVELOPMENTS

11 QUESTIONNAIRE

12 RELATED REPORTS

LIST OF TABLES

UU

TABLE 1 CLINICAL TRIAL CONDUCTED IN DIFFERENT LOCATIONS

TABLE 2 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE

TABLE 3 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 4 MIDDLE EAST AND AFRICA SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 5 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 6 MIDDLE EAST AND AFRICA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE, BY END USER, 2017-2026 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA PHARMACEUTICAL & BIOTECHNOLOGY IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA CONTRACT RESEARCH ORGANIZATIONS (CROS) IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA HOSPITALS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA KPOS/BPOS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA HEALTHCARE PROVIDERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA DIRECT SALES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA RETAIL SALES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 46 MIDDLE EAST AND AFRICA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 47 MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 48 MIDDLE EAST AND AFRICA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 49 MIDDLE EAST AND AFRICA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 50 MIDDLE EAST AND AFRICA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 51 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 52 MIDDLE EAST AND AFRICA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 53 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 54 MIDDLE EAST AND AFRICA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 55 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 56 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 57 UAE DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 58 UAE DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 59 UAE ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 60 UAE DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 61 UAE DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 62 UAE FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 63 UAE ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 64 UAE CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 65 UAE REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 66 UAE MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 67 UAE OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 68 UAE DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 69 UAE CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 70 UAE DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 71 UAE REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 72 UAE DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 73 UAE DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 74 SAUDI ARABIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 75 SAUDI ARABIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 76 SAUDI ARABIA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 77 SAUDI ARABIA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 78 SAUDI ARABIA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 79 SAUDI ARABIA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 80 SAUDI ARABIA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 81 SAUDI ARABIA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 82 SAUDI ARABIA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 83 SAUDI ARABIA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 84 SAUDI ARABIA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 85 SAUDI ARABIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 86 SAUDI ARABIA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 87 SAUDI ARABIA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 88 SAUDI ARABIA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 89 SAUDI ARABIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 90 SAUDI ARABIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 91 KUWAIT DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 92 KUWAIT DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 93 KUWAIT ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 94 KUWAIT DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 95 KUWAIT DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 96 KUWAIT FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 97 KUWAIT ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 98 KUWAIT CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 99 KUWAIT REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 100 KUWAIT MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 101 KUWAIT OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 102 KUWAIT DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 103 KUWAIT CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 104 KUWAIT DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 105 KUWAIT REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 106 KUWAIT DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 107 KUWAIT DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 108 SOUTH AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 109 SOUTH AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 110 SOUTH AFRICA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 111 SOUTH AFRICA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 112 SOUTH AFRICA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 113 SOUTH AFRICA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 114 SOUTH AFRICA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 115 SOUTH AFRICA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 116 SOUTH AFRICA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 117 SOUTH AFRICA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 118 SOUTH AFRICA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 119 SOUTH AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 120 SOUTH AFRICA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 121 SOUTH AFRICA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 122 SOUTH AFRICA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 123 SOUTH AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 124 SOUTH AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 125 REST OF MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950